The core activity of Nemosia is the development of solutions to combat neurodegenerative diseases, particularly through the development of radiopharmaceuticals and the application of Positron Emission Tomography (PET) for the diagnosis and treatment of brain disorders.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
PET tracer for the early detection of neurodegeneration, targeting the NMDA receptor; developed as a diagnostic radiotracer technology for brain imaging.
Comparisons
Nemosia AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Nemosia AG by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Nemosia AG has claimed this profile, we'll publish editorial articles and case studies here together.